Milurit (Allopurinol)

Allopurinol, the active ingredient in Milurit, is a xanthine oxidase inhibitor presented as an oral tablet for oral use. It lowers uric acid production and is employed in the management of gout, hyperuricemia, and uric‑acid kidney stones in adult patients. It is typically prescribed by physicians after laboratory confirmation of elevated serum urate levels.

GNH USA supplies Milurit as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery and regulatory compliance across multiple regions.

Allopurinol, the active component of Milurit, targets uric acid metabolism and is indicated for several gout‑related conditions.

- Gout: reduces serum uric acid levels to prevent acute flares and tophi formation in patients with chronic gout. - Hyperuricemia: maintains target uric acid concentrations, lowering the risk of disease progression in individuals with persistently elevated serum urate. - Uric acid kidney stones: decreases urinary uric acid saturation, helping to prevent formation and recurrence of uric‑acid calculi. - Asymptomatic hyperuricemia: may be used to control urate levels in patients at risk of developing gout or renal complications.

Allopurinol may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Rash: mild skin eruptions or itching. - Nausea: feeling of sickness, sometimes with vomiting. - Diarrhea: loose stools that may be watery.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin reactions requiring immediate medical attention. - Agranulocytosis: marked reduction in white blood cells, increasing infection risk. - Hepatitis: inflammation of the liver that can progress to failure.

When prescribing Milurit, clinicians should consider several precautionary measures to minimise risk and optimise therapy.

- Renal impairment: adjust dose and monitor renal function regularly. - Hepatic disease: use with caution and observe liver function tests. - History of hypersensitivity: avoid use in patients with known allergy to allopurinol. - Concomitant azathioprine or mercaptopurine: monitor blood counts for myelosuppression. - Pregnancy and lactation: prescribe only if potential benefit outweighs potential risk. - Store at ambient temperature: keep tablets in original container, protect from moisture and heat.

Allopurinol can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Azathioprine: increased risk of bone marrow suppression. - Mercaptopurine: heightened toxicity due to reduced metabolism. - Warfarin: possible increase in INR and bleeding risk. - Theophylline: elevated plasma concentrations leading to toxicity.

Moderate Interactions (Monitor Closely): - Diuretics (e.g., thiazides): may precipitate allopurinol hypersensitivity; monitor for rash. - ACE inhibitors: watch renal function and serum uric acid levels. - NSAIDs: may affect uric acid excretion; monitor urate concentrations.